Kulkarni Samarth
- SEC CIK
- 0001682019
In the past year, 7 open-market sale filings worth $10.8M and no purchases.
Current role at each company
- BDTX Black Diamond Therapeutics, Inc.Directoras of Jun 29, 2026
- CNTA Centessa Pharmaceuticals plcDirectoras of Jun 24, 2026
- ORKA Oruka Therapeutics, Inc.Directoras of Jun 3, 2026
- CRSP CRISPR Therapeutics AGChief Executive Officeras of Mar 24, 2026
- RPTX Repare Therapeutics Inc.Directoras of Jun 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $10.8M
- 7 filings
- Net
- −$10.8M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kulkarni Samarth as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRSP CRISPR Therapeutics AG
Chief Executive Officer36 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2021 (view filing) | Aug 4 | 2 days | Kulkarni SamarthChief Executive Officer | SSale | −1.50K | $125.02 | −$187.5K | −0.8%187.7K after | |
| Aug 6, 2021 (view filing) | Aug 5 | 1 day | Kulkarni SamarthChief Executive Officer | SSale | −28.5K | $128.98 | −$3.68M | −13.2%187.7K after | 5 lots |
| Jul 1, 2022 (view filing) | Jun 29 | 2 days | Kulkarni SamarthChief Executive Officer | SSale | −25.0K | $61.59 | −$1.54M | −7.9%290.3K after | 2 lots |
| Jul 29, 2022 (view filing) | Jul 27 | 2 days | Kulkarni SamarthChief Executive Officer | SSale | −25.0K | $75.91 | −$1.90M | −7.9%290.3K after | 6 lots |
| Aug 31, 2022 (view filing) | Aug 29 | 2 days | Kulkarni SamarthChief Executive Officer | SSale | −25.0K | $66.85 | −$1.67M | −7.9%290.3K after | 3 lots |
| Sep 30, 2022 (view filing) | Sep 28 | 2 days | Kulkarni SamarthChief Executive Officer | SSale | −25.0K | $64.61 | −$1.62M | −7.9%290.3K after | 2 lots |
| Oct 28, 2022 (view filing) | Oct 26 | 2 days | Kulkarni SamarthChief Executive Officer | SSale | −25.0K | $54.81 | −$1.37M | −7.9%290.3K after | 4 lots |
| Nov 30, 2022 (view filing) | Nov 28 | 2 days | Kulkarni SamarthChief Executive Officer | SSale | −25.0K | $54.03 | −$1.35M | −7.9%290.3K after | 3 lots |
| Dec 30, 2022 (view filing) | Dec 28 | 2 days | Kulkarni SamarthChief Executive Officer | SSale | −25.0K | $40.93 | −$1.02M | −6.3%369.1K after | 2 lots |
| Jan 31, 2023 (view filing) | Jan 27 | 4 days | Kulkarni SamarthChief Executive Officer | SSale | −25.0K | $51.47 | −$1.29M | −6.3%369.1K after | 2 lots |